Berwyn Radiation Oncology Center entered the industry of Medical Groups in 0 and has grown to employ 1 to 4 people, generating an annual revenue of $1.000.000 to $2.499.999. The NAICS classifies this business under the code 6219993, which describes it as a Medical Groups. For further clarification, the SIC classifies this business under the code 8099 and described it as a Medical Groups. The business provides service to the B2C market.
To acquire more information, please contact Maria Pieruccini, Manager by calling (708) 484-0011 during business hours. You can also write to the business’ Single Location at 6801 34th St # 107, Berwyn, Illinois IL 60402. You can also visit the company’s website at nuclear-oncology.com. View this business’ social media profiles on Twitter or on Facebbok .
| Company: | Berwyn Radiation Oncology Center |
| Representative: | Maria Pieruccini, Manager |
| Place of Business: | 6801 34th St # 107, Berwyn, IL 60402 |
| Contact Number: | (708) 484-0011 |
| Website: | nuclear-oncology.com |
| Type of Service: | Medical Groups |
| SIC Number: | 8099 |
| NAICS Number: | 6219993 |
| Locality: | Single Location |
| Market Type: | B2C (Business to Consumer) |
| Income/Year: | $1.000.000 to $2.499.999 |
| Laborers: | 1 to 4 |
| Share This Company: |
Berwyn Radiation Oncology Center is a company operating from Cook, Illinois providing professional Medical Groups and relevant B2C variables. It was founded in 0 and registered with the SIC code 8099 as Medical Groups, and with the NAICS code 6219993 as Medical Groups.
With a current employee count of 1 to 4, Berwyn Radiation Oncology Center has gone to report making $1.000.000 to $2.499.999 per annum on its journey towards growth. This company invites you to contact its representative Maria Pieruccini, Manager at (708) 484-0011 for related queries, or to locate its Single Location using the coordinates 41.8305,-87.79318.
The Single Location can also be found at the street address 6801 34th St # 107 in Berwyn, Illinois 60402 and can be engaged online through the company website at nuclear-oncology.com, the company Twitter , and Facebook page .